PCR technology market seen reaching $26.69 billion by 2030

The biological polymerase chain reaction technology market is projected to grow from $16.62 billion in 2025 to $26.69 billion by 2030, driven by molecular diagnostics, infectious disease testing and broader use in oncology and genetic testing. North America led the market in 2025, while Asia-Pacific is expected to be the fastest-growing region.

Why it matters: - Biological PCR technology is becoming a core tool for faster disease detection, genomic research and diagnostics. - The market’s growth reflects rising demand for high-accuracy testing in infectious diseases, oncology and personalized medicine. - The scale of projected expansion points to continued investment in laboratory automation, software and point-of-care systems.

What happened: - The biological polymerase chain reaction technology market was valued at $16.62 billion in 2025. - The market is forecast to reach $18.31 billion in 2026, up 10.2% from 2025. - The market is projected to rise to $26.69 billion by 2030, growing at a 9.9% CAGR through the end of the decade. - The Business Research Company published the market outlook in its 2026 report on biological PCR technology. - A free sample of the report is available here. - The full report is available here.

The details: - PCR amplifies specific DNA segments from small samples through repeated heating and cooling cycles. - The technique separates DNA strands, allows primers to attach and enables enzymes to synthesize new DNA copies. - The process produces large quantities of targeted DNA sequences with high accuracy and precision. - Broad adoption of molecular diagnostics helped drive historical growth in the market. - Increased use of PCR in infectious disease testing also supported demand. - Rising genomic research activity added to market growth. - Demand for precise nucleic acid amplification and advances in thermal cycler technology contributed to expansion. - The forecast through 2030 is supported by growing use of point-of-care PCR systems. - Oncology and genetic testing applications are expected to expand. - Personalized medicine, laboratory automation and rapid diagnostic solutions are also expected to lift demand. - Key trends include real-time PCR and digital PCR adoption. - High-sensitivity molecular diagnostics, PCR data analysis software integration, multiplex PCR and high-throughput applications are also gaining ground. - Workflow automation is becoming a stronger focus across the sector.

Between the lines: - Infectious disease pressure remains a major demand driver for PCR tools. - The World Health Organization reported in December 2024 that malaria caused an estimated 263 million cases globally in 2023, up from about 252 million in 2022. - WHO said malaria deaths reached 597,000 in 2023, with 94% of cases and 95% of deaths in the WHO African Region. - Those figures underscore why rapid and precise pathogen detection remains a priority for healthcare systems. - North America was the largest regional market in 2025, reflecting strong healthcare infrastructure and research capacity. - Asia-Pacific is expected to be the fastest-growing region because of higher healthcare investment, broader molecular diagnostics adoption and rising disease burden.

What's next: - The market report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 edition adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards and market hotspots infographics. - The report also adds key technologies, future trend analysis and updated graphics and tables. - The Business Research Company invited readers to contact its experts for more information. - Contact details provided in the release include Saumya Sahay at marketing@tbrc.info and the company’s regional phone numbers.

The bottom line: - PCR technology remains a fast-growing diagnostics and research market, with the strongest upside tied to infectious disease testing, precision medicine and automation.